PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma

Pathology. 2022 Jun;54(4):409-416. doi: 10.1016/j.pathol.2021.09.013. Epub 2021 Dec 3.

Abstract

Cancer immunomodulation has been implicated in the development of oral squamous cell carcinoma (OSCC), however the role of specific immunomodulatory proteins is not completely understood, particularly in the early stages of the disease. Oral potentially malignant disorders such as leukoplakia commonly precede OSCC but not all will undergo malignant transformation. The aim of this study was to evaluate the diagnostic utility of specific immunomodulator proteins and their role in the progression of OSCC. Samples from 101 patients were included in the study. Cases were classified based on histopathology into four groups: non-dysplastic epithelial hyperplasia/keratosis, low-grade dysplasia, high-grade dysplasia, and OSCC. The PD-1/PD-L1 pathway, as well as regulatory T cell (Treg)-related proteins including FOXP3, TGF-β, IL-6, and IL-10 were immunohistochemically quantified. The number of tumour-infiltrating lymphocytes (TILs) was also assessed for each case. Multinominal regression models were undertaken to assess the significance of each protein in predicting the histopathological grade of oral epithelial disorders, and three diagnostic models were assessed. Significant positive associations were found between the immunoreactive score of each protein and the histopathological grade, p<0.05 suggesting that the PD-1/PD-L1 pathway, Treg-related proteins, and TILs are associated with the development of OSCC. Diagnostic models using the investigated proteins and TILs predicted the grade of oral epithelial disorder, p<0.05. The associated accuracy of this approach was 84.92%. Our findings support the notion that immunomodulation events may play a role in evading the immune system and contributing to potential malignant transformation of oral epithelial disorders. Our data also provide supporting evidence for the potential application of immune checkpoint inhibitors in the chemoprevention of OSCC. Further longitudinal studies to assess individual T-cell populations within the immune microenvironment of various oral potentially malignant disorders are warranted.

Keywords: Tumour-infiltrating lymphocytes; immunomodulatory; oral carcinogenesis; oral epithelial dysplasia; squamous cell carcinoma.

MeSH terms

  • B7-H1 Antigen / metabolism
  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms* / metabolism
  • Humans
  • Lymphocytes, Tumor-Infiltrating
  • Mouth Neoplasms* / pathology
  • Precancerous Conditions*
  • Programmed Cell Death 1 Receptor / metabolism
  • Squamous Cell Carcinoma of Head and Neck / metabolism
  • T-Lymphocytes, Regulatory / metabolism
  • Tumor Microenvironment

Substances

  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor